US Patent 12,337,024 — assignment history and current owner
US 12,337,024 · Application 17/635,441
Larazotide Formulations
Who owns US Patent 12,337,024?
US12337024 ("Larazotide Formulations") — current assignee: INTERLUDE BIOPHARMA CO.. Status: Active, estimated expiration December 25, 2040. 5 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,337,024 is INTERLUDE BIOPHARMA CO.. Based on the most recent name change record (recorded 2024-05-21).
- Patent title
- Larazotide Formulations
- Application number
- 17/635,441
- Apparent operating assignee
- INTERLUDE BIOPHARMA CO.
- Patent status
- Active, estimated expiration December 25, 2040
- Recorded assignments
- 5
Note: a security interest appears active (HIGH TRAIL SPECIAL SITUATIONS LLC) with no recorded release. Security interests reflect financing arrangements, not operating ownership.
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Apr 15, 2020 | Jan 25, 2023 | Ownership Transfer | MADAN, JAY P.; MUSSO, GARY F.; RADHAKRISHNAN, BALASINGHAM | INNOVATE BIOPHARMACEUTICALS, INC. | 62479/710 |
| Apr 30, 2020 | Jan 25, 2023 | Name Change | INNOVATE BIOPHARMACEUTICALS, INC. | 9 METERS BIOPHARMA, INC. | 62492/981 |
| Jul 15, 2022 | Apr 10, 2023 | Security Agreement | 9 METERS BIOPHARMA, INC.; NAIA RARE DISEASES, LLC | HIGH TRAIL SPECIAL SITUATIONS LLC | 63281/653 |
| Jan 8, 2024 | May 21, 2024 | Ownership Transfer | 9 METERS BIOPHARMA, INC. | EBRIS PHARMA CO. | 67486/234 |
| Apr 1, 2024 | May 21, 2024 | Name Change | EBRIS PHARMA CO. | INTERLUDE BIOPHARMA CO. | 67486/847 |
Scrolls sideways on narrow screens
Chain of title
In 2023, MADAN, JAY P.; MUSSO, GARY F. (+1 more) assigned the patent to INNOVATE BIOPHARMACEUTICALS, INC.. The most recent ownership transfer, recorded in 2024, lists EBRIS PHARMA CO. as assignee. In 2024, EBRIS PHARMA CO. changed its name to INTERLUDE BIOPHARMA CO.. In 2023, HIGH TRAIL SPECIAL SITUATIONS LLC recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
Ownership settled? Give your AI the file.
Application 17/635,441 · US 12,337,024
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,337,024, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.